Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.

R. S. Shirey, J. S. Boyd, A. V. Parwani, W. S. Tanz, Paul Michael Ness, Karen Eileen King

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Patients with warm autoantibodies are at high risk for delayed hemolytic transfusion reactions due to the presence of alloantibodies. To provide blood safe for transfusion and to avoid adsorption studies in some cases, the provision of prophylactic antigen-matched donor blood where feasible for patients with warm autoantibodies is advocated. STUDY DESIGN AND METHODS: Twenty consecutive adult patients with warm autoantibodies (January 1999 to February 2000) received chronic RBC transfusions by use of this protocol: the serology consistent with warm autoantibodies was confirmed; the alloantibodies were identified; the complete phenotype was determined (i.e., C, E, c, e, K, Jk(a), Jk(b), Fy(a), Fy(b), S, and s); and prophylactic antigen-matched (i.e., donor RBCs matched with the patient's phenotype), WBC-reduced donor RBCs were provided for transfusion. On subsequent admissions, samples were evaluated by panel studies and DATs. If the serology remained consistent with previous findings, prophylactic antigen-matched, WBC-reduced RBCs were transfused without further testing. RESULTS: Eight of 20 (40%) patients had existing, clinically significant alloantibodies. In 12 of 20 (60%) patients, a phenotype was determined and the patients received transfusion of a total of 149 prophylactic antigen-matched RBC units (mean, 15 units per patient) precluding adsorption studies on 51 pretransfusion samples. In 8 of 20 (40%) cases (2 with alloantibodies), phenotypes were indeterminant, necessitating differential allogeneic adsorption studies on 39 samples before transfusion of 144 RBC units (mean, 18 units per patient). CONCLUSIONS: Determining complete phenotypes should be a routine component of the serologic evaluation of patients with warm autoantibodies. Our algorithm for providing prophylactic antigen-matched RBCs to these patients when a complete phenotype can be determined provides flexibility in their transfusion management while maintaining safety and circumvents or simplifies pretransfusion adsorption studies.

Original languageEnglish (US)
Pages (from-to)1435-1441
Number of pages7
JournalTransfusion
Volume42
Issue number11
StatePublished - Nov 2002

Fingerprint

Blood Donors
Autoantibodies
Antigens
Isoantibodies
Phenotype
Adsorption
Serology
Tissue Donors
Blood Transfusion
Safety

ASJC Scopus subject areas

  • Hematology
  • Immunology

Cite this

Shirey, R. S., Boyd, J. S., Parwani, A. V., Tanz, W. S., Ness, P. M., & King, K. E. (2002). Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management. Transfusion, 42(11), 1435-1441.

Prophylactic antigen-matched donor blood for patients with warm autoantibodies : an algorithm for transfusion management. / Shirey, R. S.; Boyd, J. S.; Parwani, A. V.; Tanz, W. S.; Ness, Paul Michael; King, Karen Eileen.

In: Transfusion, Vol. 42, No. 11, 11.2002, p. 1435-1441.

Research output: Contribution to journalArticle

Shirey, RS, Boyd, JS, Parwani, AV, Tanz, WS, Ness, PM & King, KE 2002, 'Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.', Transfusion, vol. 42, no. 11, pp. 1435-1441.
Shirey, R. S. ; Boyd, J. S. ; Parwani, A. V. ; Tanz, W. S. ; Ness, Paul Michael ; King, Karen Eileen. / Prophylactic antigen-matched donor blood for patients with warm autoantibodies : an algorithm for transfusion management. In: Transfusion. 2002 ; Vol. 42, No. 11. pp. 1435-1441.
@article{871f73f3833748cba4b0ca281c0db8c8,
title = "Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.",
abstract = "BACKGROUND: Patients with warm autoantibodies are at high risk for delayed hemolytic transfusion reactions due to the presence of alloantibodies. To provide blood safe for transfusion and to avoid adsorption studies in some cases, the provision of prophylactic antigen-matched donor blood where feasible for patients with warm autoantibodies is advocated. STUDY DESIGN AND METHODS: Twenty consecutive adult patients with warm autoantibodies (January 1999 to February 2000) received chronic RBC transfusions by use of this protocol: the serology consistent with warm autoantibodies was confirmed; the alloantibodies were identified; the complete phenotype was determined (i.e., C, E, c, e, K, Jk(a), Jk(b), Fy(a), Fy(b), S, and s); and prophylactic antigen-matched (i.e., donor RBCs matched with the patient's phenotype), WBC-reduced donor RBCs were provided for transfusion. On subsequent admissions, samples were evaluated by panel studies and DATs. If the serology remained consistent with previous findings, prophylactic antigen-matched, WBC-reduced RBCs were transfused without further testing. RESULTS: Eight of 20 (40{\%}) patients had existing, clinically significant alloantibodies. In 12 of 20 (60{\%}) patients, a phenotype was determined and the patients received transfusion of a total of 149 prophylactic antigen-matched RBC units (mean, 15 units per patient) precluding adsorption studies on 51 pretransfusion samples. In 8 of 20 (40{\%}) cases (2 with alloantibodies), phenotypes were indeterminant, necessitating differential allogeneic adsorption studies on 39 samples before transfusion of 144 RBC units (mean, 18 units per patient). CONCLUSIONS: Determining complete phenotypes should be a routine component of the serologic evaluation of patients with warm autoantibodies. Our algorithm for providing prophylactic antigen-matched RBCs to these patients when a complete phenotype can be determined provides flexibility in their transfusion management while maintaining safety and circumvents or simplifies pretransfusion adsorption studies.",
author = "Shirey, {R. S.} and Boyd, {J. S.} and Parwani, {A. V.} and Tanz, {W. S.} and Ness, {Paul Michael} and King, {Karen Eileen}",
year = "2002",
month = "11",
language = "English (US)",
volume = "42",
pages = "1435--1441",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Prophylactic antigen-matched donor blood for patients with warm autoantibodies

T2 - an algorithm for transfusion management.

AU - Shirey, R. S.

AU - Boyd, J. S.

AU - Parwani, A. V.

AU - Tanz, W. S.

AU - Ness, Paul Michael

AU - King, Karen Eileen

PY - 2002/11

Y1 - 2002/11

N2 - BACKGROUND: Patients with warm autoantibodies are at high risk for delayed hemolytic transfusion reactions due to the presence of alloantibodies. To provide blood safe for transfusion and to avoid adsorption studies in some cases, the provision of prophylactic antigen-matched donor blood where feasible for patients with warm autoantibodies is advocated. STUDY DESIGN AND METHODS: Twenty consecutive adult patients with warm autoantibodies (January 1999 to February 2000) received chronic RBC transfusions by use of this protocol: the serology consistent with warm autoantibodies was confirmed; the alloantibodies were identified; the complete phenotype was determined (i.e., C, E, c, e, K, Jk(a), Jk(b), Fy(a), Fy(b), S, and s); and prophylactic antigen-matched (i.e., donor RBCs matched with the patient's phenotype), WBC-reduced donor RBCs were provided for transfusion. On subsequent admissions, samples were evaluated by panel studies and DATs. If the serology remained consistent with previous findings, prophylactic antigen-matched, WBC-reduced RBCs were transfused without further testing. RESULTS: Eight of 20 (40%) patients had existing, clinically significant alloantibodies. In 12 of 20 (60%) patients, a phenotype was determined and the patients received transfusion of a total of 149 prophylactic antigen-matched RBC units (mean, 15 units per patient) precluding adsorption studies on 51 pretransfusion samples. In 8 of 20 (40%) cases (2 with alloantibodies), phenotypes were indeterminant, necessitating differential allogeneic adsorption studies on 39 samples before transfusion of 144 RBC units (mean, 18 units per patient). CONCLUSIONS: Determining complete phenotypes should be a routine component of the serologic evaluation of patients with warm autoantibodies. Our algorithm for providing prophylactic antigen-matched RBCs to these patients when a complete phenotype can be determined provides flexibility in their transfusion management while maintaining safety and circumvents or simplifies pretransfusion adsorption studies.

AB - BACKGROUND: Patients with warm autoantibodies are at high risk for delayed hemolytic transfusion reactions due to the presence of alloantibodies. To provide blood safe for transfusion and to avoid adsorption studies in some cases, the provision of prophylactic antigen-matched donor blood where feasible for patients with warm autoantibodies is advocated. STUDY DESIGN AND METHODS: Twenty consecutive adult patients with warm autoantibodies (January 1999 to February 2000) received chronic RBC transfusions by use of this protocol: the serology consistent with warm autoantibodies was confirmed; the alloantibodies were identified; the complete phenotype was determined (i.e., C, E, c, e, K, Jk(a), Jk(b), Fy(a), Fy(b), S, and s); and prophylactic antigen-matched (i.e., donor RBCs matched with the patient's phenotype), WBC-reduced donor RBCs were provided for transfusion. On subsequent admissions, samples were evaluated by panel studies and DATs. If the serology remained consistent with previous findings, prophylactic antigen-matched, WBC-reduced RBCs were transfused without further testing. RESULTS: Eight of 20 (40%) patients had existing, clinically significant alloantibodies. In 12 of 20 (60%) patients, a phenotype was determined and the patients received transfusion of a total of 149 prophylactic antigen-matched RBC units (mean, 15 units per patient) precluding adsorption studies on 51 pretransfusion samples. In 8 of 20 (40%) cases (2 with alloantibodies), phenotypes were indeterminant, necessitating differential allogeneic adsorption studies on 39 samples before transfusion of 144 RBC units (mean, 18 units per patient). CONCLUSIONS: Determining complete phenotypes should be a routine component of the serologic evaluation of patients with warm autoantibodies. Our algorithm for providing prophylactic antigen-matched RBCs to these patients when a complete phenotype can be determined provides flexibility in their transfusion management while maintaining safety and circumvents or simplifies pretransfusion adsorption studies.

UR - http://www.scopus.com/inward/record.url?scp=0036831966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036831966&partnerID=8YFLogxK

M3 - Article

C2 - 12421216

AN - SCOPUS:0036831966

VL - 42

SP - 1435

EP - 1441

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 11

ER -